Journalartikel

Increased prevalence of anti-DFS70 antibodies in young females: experience from a large international multi-center study on blood donors


AutorenlisteAlbesa, Roger; Sachs, Ulrich; Infantino, Maria; Manfredi, Mariangela; Benucci, Maurizio; Baus, Yvonne; Lutterbeck, Silke; Andrade, Luis; Morris, Kieran; Friedenberg, Alice; Casas, Silvia; Bossuyt, Xavier; Mahler, Michael

Jahr der Veröffentlichung2019

Seiten999-1005

ZeitschriftClinical Chemistry and Laboratory Medicine

Bandnummer57

Heftnummer7

ISSN1434-6621

eISSN1437-4331

DOI Linkhttps://doi.org/10.1515/cclm-2018-1233

VerlagDe Gruyter


Abstract

Background: Isolated antibodies to DFS70 have been described in healthy individuals and are rarely found in patients with antinuclear antibody-associated autoimmune rheumatic diseases (AARD). However, no data is available on geographic differences in the prevalence of anti-DFS70 antibodies. We aimed to study the prevalence of anti-DFS70 antibodies in blood donor samples from several countries representing various ethnical backgrounds and geographic regions in the world.

Methods: Sera from apparently healthy blood donors (n >= 300 per site) were collected in seven countries (USA, Italy, Spain, Germany, UK, Belgium and Brazil). All samples (n=2628) were tested for anti-DFS70 antibodies by QUANTA Flash DFS70 (Inova Diagnostics, Inc., San Diego, CA, USA).

Results: The prevalence of anti-DFS70 antibodies varied from 4/321 (1.2%, Italy) to 42/497 (8.5%, USA). Consequently, the prevalence of the antibodies was significantly higher in USA compared to all other countries (p <0.05). In addition, the prevalence in the combined cohort (all sites) was higher in young blood donors (<35 years; 5.0% vs. 2.7%; p = 0.0017) and among females (4.5% vs. 3.0%; p = 0.0446). However, when cohorts from different countries were corrected for age and gender, no significant difference between the countries were found.

Conclusions: This is the first study to analyze the prevalence of anti-DFS70 antibodies in different geographic areas using a standardized assay. Our findings show that the antibodies are most prevalent in young females.




Zitierstile

Harvard-ZitierstilAlbesa, R., Sachs, U., Infantino, M., Manfredi, M., Benucci, M., Baus, Y., et al. (2019) Increased prevalence of anti-DFS70 antibodies in young females: experience from a large international multi-center study on blood donors, Clinical Chemistry and Laboratory Medicine, 57(7), pp. 999-1005. https://doi.org/10.1515/cclm-2018-1233

APA-ZitierstilAlbesa, R., Sachs, U., Infantino, M., Manfredi, M., Benucci, M., Baus, Y., Lutterbeck, S., Andrade, L., Morris, K., Friedenberg, A., Casas, S., Bossuyt, X., & Mahler, M. (2019). Increased prevalence of anti-DFS70 antibodies in young females: experience from a large international multi-center study on blood donors. Clinical Chemistry and Laboratory Medicine. 57(7), 999-1005. https://doi.org/10.1515/cclm-2018-1233



Schlagwörter


antinuclear antibodiesAUTOANTIBODIESAutoimmune diseaseDFSHEALTHY-INDIVIDUALSHEP-2 CELLSLEDGELEDGF/P75LUPUSPERFORMANCE EVALUATION


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-02-04 um 01:03